Gnanasakthy A, Norcross L, Fitzgerald K. Editorial - Assessment of patient-reported outcomes in industry-sponsored phase 1 oncology studies: considerations for translating theory into practice. Value Health. 2023 Jun 21;26(10):1440-3. doi: 10.1016/j.jval.2023.06.006
Gnanasakthy A, Norcross L, (DeMuro) Romano C, Carson RT. A review of patient-reported outcome labeling of FDA-approved new drugs (2016-2020): counts, categories, and comprehensibility. Value Health. 2022 Apr;25(4):647-55. doi: 10.1016/j.jval.2021.10.006
Gnanasakthy A, Barrett A, Norcross L, D’Alessio D, Romano (DeMuro) C. Use of patient and investigator global impression scales: a review of Food and Drug Administration–approved labeling, 2009 to 2019. Value Health. 2021 Jul;24(7):1016-23. doi: 10.1016/j.jval.2021.01.005
Filonenko A, Purser M, Mader G, Graham J. Impact of increased utilization of long-acting reversable contraceptive methods among young women on cost and unintended pregnancies (UP) in the United States (US). Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S153. doi: 10.1016/j.jval.2020.04.371
Gnanasakthy A, Barrett A, D'Alessio D, Norcross L. Review of patient and clinician global assessments in PRO labeling (2017-2019). Poster presented at the ISPOR Virtual 2020 Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S299. doi: 10.1016/j.jval.2020.04.094
Goyal RK, Ajmera MR, Davis KL. Recent trends in emergency department visits resulting from unintentional overdose of non-opioid analgesics, antipyretics, and antirheumatics in the United States. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A231.
Gnanasakthy A, Mordin M, Evans E, Doward L, DeMuro C. A review of patient-reported outcome labeling in the United States (2011-2015). Value Health. 2017;20(3):420-9. doi: 10.1016/j.jval.2016.10.006
Gnanasakthy A, DeMuro C. Outcome assessments of primary endpoints of new drugs approved by the FDA (2011-2015). Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 25, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A275.
Reese ES, Kurosky SK, Candrilli S. Recent trends in urgent antibacterial threat-related hospitalization in the US. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A234-5.
Meyers JL, Candrilli SD. Common reasons for and associated burden of inpatient admissions among children in the United States. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A252-3.
Mauskopf J, Chirila C, Masaquel CJ, Boye KS, Bowman L, Birt J, Grainger DB. The relationship between financial impact and the likelihood of drug reimbursement in the Australian health care system. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 26, 2011. [abstract] Value Health. 2011 May; 14(3):A22-3.
Doward LC, Meads DM, Fisk J, Twiss J, Hagell P, Opra N, Grand'Maison F, Bhan V, Arbizu T, Kohlmann T, Brassat D, Eckert B, McKenna S. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value Health. 2010;13(4):463-8.
de Cambra S, Mladsi D, Neale S, Faulkner EC. Reimbursement of active immunotherapeutics: an analysis based on a study of current reimbursement approaches. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A288. doi: 10.1111/j.1524-4733.2009.00592_1.x
Gonzalez-Rojas N, Vieta A, Monreal M, Wolowacz SE. Economic analysis of dabigatran etexilate for the primary prevention of venous thromboembolism following total hip or knee replacement in Spain. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 24, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A440.
Candrilli S, Davis KL, Mitra D, Tortella BJ, Joshi AV. Inpatient costs and outcomes associated with traumatic injury in the United States by injury severity and trauma center designation. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A97.
Zhou X, Radigue C, Maneval F, Coste F. Validity of data collected from an internet-based cohort study. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence. [abstract] Value Health. 2005 Nov; 8(6):A76.
Dombeck M, Earnshaw SR, Candrilli SD, Xuan J, Bakst A, Kirsch JM. Modeling antibiotic efficacy by infectious agent and probability of resistance. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 4th Annual European Congress; November 2001. [abstract] Value Health. 2001 Sep; 4(6):427.